ClinicalTrials.Veeva

Menu

Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus

Zhejiang University logo

Zhejiang University

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03136939
2016-420

Details and patient eligibility

About

10 type 1 diabetes, 10 type 2 diabetes and 10 healthy controls matched with age and sex were enrolled in our study and their periphera blood mononuclear cells (PBMC) were isolated. We implemented ELISPOT(Enzyme-linked Immunospot Assay) to detect the interferon-γ (IFN-γ)which secreted by IGRP-specific T cell. Results were compared between these groups.

Enrollment

30 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • the criteria of type 1 and type 2 diabetes

Exclusion criteria

  • no diabetes

Trial design

30 participants in 3 patient groups

type 1 diabetes
Treatment:
Other: No intervention
type 2 diabetes
Treatment:
Other: No intervention
healthy people
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems